PSYG.F Stock Overview
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Psyence Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.015 |
| 52 Week High | CA$0.22 |
| 52 Week Low | CA$0.013 |
| Beta | 0.24 |
| 1 Month Change | -61.29% |
| 3 Month Change | -42.16% |
| 1 Year Change | -84.24% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| PSYG.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -16.7% | 1.3% | 3.3% |
| 1Y | -84.2% | 3.0% | 25.0% |
Return vs Industry: PSYG.F underperformed the US Biotechs industry which returned 3.4% over the past year.
Return vs Market: PSYG.F underperformed the US Market which returned 25.8% over the past year.
Price Volatility
| PSYG.F volatility | |
|---|---|
| PSYG.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PSYG.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PSYG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | n/a | www.psyence.com |
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement.
Psyence Group Inc. Fundamentals Summary
| PSYG.F fundamental statistics | |
|---|---|
| Market cap | US$2.53m |
| Earnings (TTM) | -US$3.74m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.7x
P/E RatioIs PSYG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PSYG.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$5.13m |
| Earnings | -CA$5.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.037 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did PSYG.F perform over the long term?
See historical performance and comparison